a cure for hep c, aids, the flu and dengue..., page-9

  1. 1,843 Posts.
    G'day Dentons. We're right at the point where it all either pays or doesn't. My understanding is that there are a LOT of majors watching this trial very very closely, with particular interest from the US. Success and the subsequent capital raising will see the company in a position to negotiate a partnership at favourable terms.

    I must commend Michelle Miller (MD) for what I see as very successful management of the amount of stock on issue. After such extensive work, the company is on the cusp of demonstrating viability with only 121 million shares on issue ( plus roughly 122 million options, all out of the money to various degrees).

    Michelle, you are rubbish at keeping the market updated. Absolutely rubbish. In my mind however, your ability to manage the number of shares on issue more than offsets this shortcoming. I rarely take to thanking any MD before a project is proven but in your case it is almost impossible to imagine getting to this point with so few shares on issue. Well done and thank you.

 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.2¢
Change
0.000(0.00%)
Mkt cap ! $2.654M
Open High Low Value Volume
0.2¢ 0.2¢ 0.2¢ $450 225K

Buyers (Bids)

No. Vol. Price($)
50 29340627 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 16618992 22
View Market Depth
Last trade - 14.34pm 11/07/2025 (20 minute delay) ?
BIT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.